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Summary Apoptosis plays critical role in diabetic cardiomyopathy and endoplasmic reticulum
stress (ERS) is one of intrinsic apoptosis pathways. For previous studies have shown that endo-
plasmic reticulum become swell in diabetic myocardium and ERS was involved in diabetes
mellitus and heart failure, this study aimed to demonstrate whether ERS was induced in
myocardium of streptozocin (STZ)-induced diabetic rats. We established type 1 diabetic rat
model with STZ intraperitoneal injection, used echocardiographic evaluation, hematoxylin-
eosin staining and the terminal deoxynucleotidyl transferase-mediated DNA nick-end labeling
staining to identify the existence of diabetic cardiomyopathy and enhanced apoptosis in the
diabetic heart. We performed immunohistochemistry, Western blot and real time PCR to
analysis two hallmarks of ERS, glucose regulated protein78 (Grp78) and Caspase12. We found
both Grp78 and Caspase12 had enhanced expression in protein and mRNA levels in diabetic
myocardium than normal rat’s, and Caspase12 was activated in diabetic heart. Those results
suggested that ERS was induced in STZ-induced diabetic rats’ myocardium, and ERS-associ-
ated apoptosis took part in the pathophysiology of diabetic cardiomyopathy.
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Introduction
In humans and animal models of diabetes, a heart muscle-
specific disease in the absence of any vascular pathology has
been described, termed diabetic cardiomyopathy [1, 2]. The
pathogenesis of diabetic cardiomyopathy is a chronic and
complex process that is attributed to abnormal cellular
metabolism and defects in organelles such as myofibrils,
mitochondria, sarcolemma, and endoplasmic reticulum (ER)
[3–7]. However, the mechanisms of diabetic cardiomyopathy
are not fully known, and appropriate approaches to minimize
these risks are still being explored. Probable candidates to
explain this heart disease include autonomic abnormalities,
metabolic disorders, abnormal enzyme function, and inter-
stitial fibrosis [8–10]. Apoptosis, a regulated, energy-
dependent, cell suicide mechanism was also been reported to
play a critical role in the development of diabetic cardio-
myopathy [3, 11, 12].
As an organelle involved in the intrinsic pathway of
apoptosis [13], the ER serves several important functions
and participates in the folding of secretory and membrane
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proteins. Various conditions can disturb ER’s functions
and result in endoplasmic reticulum stress (ERS), these
conditions include ischemia, hypoxia, gene mutation,
elevated protein synthesis, and exposure to free radicals.
Several signaling pathways are initiated to cope with ERS,
which were designated as the unfolded protein response
(UPR) [14]. One major pathway of UPR is up-regulate
expression of ER-localized molecular chaperons, such as
glucose regulated protein 78 (Grp78), which can contribute
to repair unfolded proteins. When ERS become increased or
UPR is compromised, cell apoptosis can be led through
known ways including activating Caspase12, which is a
representative caspase implicated in the cell death-executing
mechanisms relevant to ERS [15].
Evidences have demonstrated that apoptosis initiated by the
ERS was involved in pathogenesis of diabetes and heart failure
[16–18], and ultrastructural analysis found ER was swelling
in diabetic model’s myocardium [19, 20], but the relationship
between ERS and diabetic cardiomyopathy is unknown.
Materials and Methods
Animals
Thirty male Wistar rats from animal center of Shandong
University (8 weeks of age; mean body weight 280 ± 10 g)
were used. The rats were housed by cage with free access to
normal rat diet and tap water of the center. They were
maintained under conditions of standard lighting (alternating
12 h light/dark cycle), temperature (22 ± 0.5°C) and humidity
(60 ± 10%) for at least 1 week before the experiments. All
experiments were carried out in accordance with the
recommendations of the Institutional Animal Care and Use
Committee of Shandong University. Twenty rats were given
a single intraperitoneal dose (65 mg/kg) of STZ (S0130,
Sigma-Aldrich, MO) while the rest 10 rats were given a
same dosage of saline. Diabetes was confirmed by
measuring the venous circulating plasma concentrations of
glucose. Seven days post-STZ injection, blood samples were
obtained from the rat-tail vein and the glucose concentration
was determined with an automatic analyzer (One Touch
SureStep Meter, LifeScan, CA). Nineteen rats reached the
diabetic rat standard of a fasting blood glucose level higher
than 300 mg/dl, while the normal value in control healthy
rats injected with saline ranges from 90 to 130 mg/dl. Two
STZ-diabetic rats were died from infection at the time of 2
and 10 weeks. At the time of 16 weeks post-saline or STZ
injection, 17 STZ-diabetic rats were left, while the control
group rats were all survived.
Echocardiographic evaluation
At 16 weeks of study, before sacrifice, each rat was
anaesthetized with Ketamine HCl (50 mg/kg) and Xylazine
(10 mg/kg), placed in the left lateral decubitus position.
Chest of the rat was shaved and a layer of acoustic coupling
gel was applied to the thorax, two-dimensional and M-mode
echocardiography was performed using a commercially
available 12-MHz linear-array transducer system and
echocardiogram machine (Sonos 5500, HP, MA). M-mode
recordings were obtained of the left ventricle at the level of
mitral valve in the parasternal view using two-dimensional
echocardiographic guidance in both the short and long axis
views. Pulsed wave Doppler was used to examine mitral
diastolic inflow from the apical four chamber view. For each
measurement, data from three consecutive cardiac cycles
were averaged. All measurements were made from digital
images captured at the time of the study by use of inherent
analysis software. The results are in Table 1.
Histopathology, TUNEL stain and immunohistochemistry
Two days after echocardiographic evaluation, rats were
anaesthetized again, hearts were removed from the animals,
sliced transversely, 8 diabetic and 5 control hearts were fixed
in 4% neutral buffered formalin and then paraffin-embedded
for light microscopic evaluation. Nine diabetic and 5 control
hearts were frozen at −80°C for Western-blot and real time
PCR use. Experimental procedures were adhered to the
guidelines of Shandong University’s Code for the Care and
Use of Animals for Scientific Purposes. All studies were
performed with observer masked to study groups to which
the animals had been assigned. Hearts embedded in paraffin
were sectioned at 5 µm and studied with hematoxylin-eosin
stain, a TUNEL assay kit, and immunohistochemistry. Sections
were examined using light microscopy, and analyzed with
a computer-assisted color image analysis system (Image-
ProPlus 5.1, Media Cybernetics, MD).
Assessment for apoptosis was conducted using a
commercially available TUNEL assay kit (code number KGA
703, Keygen Biotechnology, China). Briefly, sections were
deparaffinized, digested with proteinase K (20 µg/ml), at
room temperature for 15 min, and soaked in phosphate
buffer saline (PBS) for 5 min. Each section was covered
with a terminal deoxynucleotidyl transferase (TDT) enzyme
solution containing 45 µl equilibration buffer, 1 µl biotin-
11-dUTP, 4 µl TDT enzyme and incubated for 1 h at 37°C in
Table 1. The sequence for each primer and product length
sequence length
Grp78 F5' TCAGCCCACCGTAACAAT 3' 275 bps
R5' CAAACTTCTCGGCGTCAT 3
Caspase12 F5' GGAAGGTAGGCAAGAGT 3' 179 bps
R5' GTAGAAGTAGCGTGTCATA 3'
GAPDH F5' GTCGGTGTCAACGGATTTG 3' 397 bps
R5' ACAAACATGGGGGCA TCAG 3'
The primers’ sequence and product length designed for Grp78,
Caspase12 and GAPDH.Z. Li et al.
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a humidified chamber. The sections were immersed in stop
buffer to terminate the enzymatic reaction and then gently
rinsed with PBS. 50 µl streptavidin-horseradish peroxidase
(HRP) solution containing 0.25 µl streptavidin-HRP and
49.75 µl PBS was then applied to each section and incubated at
room temperature for 30 min in the dark. Slides were washed
in PBS, exposed for 5 – 7 min to DAB + chromogen (code
number ZLI-9032, Zhongshan Golden Bridge Biotechnology,
China). Then slides were rinsed in water and counterstained
with hematoxylin. Then the sections were examined using
light microscopy. Sections incubated with PBS, instead of
TDT enzyme solution, served as the negative controls.
Tissue expression of Caspase12 and Grp78 was assessed
immunohistochemically using a polyclonal anti-Caspase12
(code number sc1611, Santa Cruz Biotechnology, CA) and a
monoclonal anti-Grp78 antibody (code number sc1050, Santa
Cruz Biotechnology, CA). After deparaffinization, endogenous
peroxidase activity was quenched with 30% methanol and
0.3% hydrogen PBS. Then the slides were boiled in citrate
buffer with microwaves. After blocking nonspecific binding
with 5% bovine serum albumin, the slides were incubated with
primary antibodies overnight at 4°C (dilutions for each anti-
body: anti-Caspase12 1:200; anti-Grp78 1:400). The following
day the sections were thoroughly washed in PBS and incubated
with a peroxidase-conjugated polymer which carries anti-
bodies to rat (1:100) and goat (1:200) immunoglobulin (code
number ZB-2307, ZB-2306 Zhongshan Golden Bridge
Biotechnology, China) for 30 min. After rinsing with PBS,
the sections were exposed for 7 min to DAB + chromogen.
The slides were rinsed in water and counterstained with
haematoxylin. The immunohistochemical staining of the
samples was performed at different times but by the same
technical personnel. Sections incubated with PBS, instead of
the primary antiserum, served as the negative controls.
RNA expression analysis
Total RNA was extracted from normal and diabetic rat
hearts by the single-step acid-guanidium-phenol chloroform
method [21] using Trizol reagent (code number 15596-026,
CA) according to the manufacturer’s instructions. RNA was
quantified by UV spectrophotometry at 260/280 nm and
diluted to 1 µg/µl in diethyl pyrocarbamate (DEPC)-treated
water. RNA samples were analyzed by formaldehyde-
agarose gel electrophoresis, and integrity was confirmed by
visualization of 18S and 28S rRNA bands. First-strand
cDNA was synthesized in a 40 µl total volume by using
oligo (dT) 12-18 primer and M-MLV reverse-transcriptase
(code number m1701, Promega, WI). To reduce pipetting
variation, a master RT mixture was prepared and added to
each of the different RNA samples. Briefly, reverse-
transcriptase was performed in a 40 µl volume mixture made
up of 6 µl of total RNA, 2 µl Olig (dT), 8 µl of reverse-
transcriptase buffer, 2 µl of 2.5 mM dNTP mixture, 2 µl M-
MLV reverse-transcriptase, and 20 µl DEPC-treated water.
The condition was incubated at 37°C for 1 h, heated at 95°C
for 5 min. The cDNA were stored at −20°C for use.
Sequence for each primer and product are in Table 2.
Real time PCR was carried out using the real time detection
system (ABI Prism 7000, CA) with a real time PCR master
mix (code number: QPK-201,Toyobo, Japan), which contains
SYBR-Green I as fluorescent dye enabling real-time detection
of PCR products, the protocol was according to the
manufacturer. A 50 µl volume mixture made up of: sense
primer 1 µl (10 µM), antisense primer 1 µl (10 µM), real time
PCR master mix 25 µl, (DEPC)-treated water 18 µl and cDNA
5 µl. Cycling conditions were 95°C for 3 min, followed by
40 cycles of 94°C for 30 s, 60°C for 30 s, and 72°C for 60 s.
For quantification, the mRNA of Grp78, Caspase12 gene
was normalized to the mRNA of the internal standard gene
glyceraldehyde phosphate dehydrogenase (GAPDH).
Table 2.  Transmitral Doppler flow velocity recordings in normal (n = 10) and diabetic
(n = 17) rats at 1st and 16th week
1st week 16th week
Normal Diabetic Normal Diabetic
E 53.25 ± 5.57 52.24 ± 5.62 55.34 ± 5.67 30.45 ± 7.56*#
A 27.34 ± 6.57 31.09 ± 5.65 28.45 ± 6.67 53.45 ± 6.87*#
E/A 2.11 ± 0.31 1.76 ± 0.13 2.05 ± 0.45 0.61 ± 0.06*#
Eat 28.15 ± 6.45 27.89 ± 5.89 27.45 ± 6.34 16.95 ± 5.45*#
Edt 48.34 ± 6.59 47.23 ± 7.12 48.98 ± 7.01 52.48 ± 7.14
EF 61.34 ± 7.76 61.57 ± 4.42 60.56 ± 5.10 38.05 ± 7.76*#
FS 27.39 ± 3.19 27.18 ± 4.67 28.16 ± 4.08 16.31 ± 5.27*#
Results shown are mean ± S.D. E: peak early transmitral filling velocity during early diastole;
A: peak transmitral atrial filling velocity during late diastole; Eat: acceleration time of E-
wave; Edt: deceleration time of E-wave; EF: ejection fraction; FS: fractional shortening.
*p<0.05 compared to 1st week data. #p<0.05 compared to normal rats.ER Stress in Diabetic Myocardial Apoptosis
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Western blot
Protein from diabetic and normal rat hearts was extracted
for western-blot use. The tissue samples were homogenized
in a lysis buffer (0.1 mol/l NaCl, 0.01 M Tris-HCl PH 7.5,
1 mM EDTA, and 1 µg/ml Aprotinin), then the homogenates
were centrifuged at 7000 g for 15 min at 4°C. The supernatants
were used as protein samples. We used a Bradford assay
(Bio-Rad Laboratories, Hercules, CA, USA) to determine
each sample’s protein concentration, then performed
Western blot analysis with a 5% acrylamide stacking gel and
a 14% acrylamide resolving gel, 60 µg of protein was sub-
jected to gel electrophoresis. Proteins from the gel to nitro-
cellulose membranes (code number LC2006, Invitrogen,
CA) was performed for 50 min at 120 V. Nonspecific protein
binding to the nitrocellulose membrane was reduced by pre-
incubating the membrane with blocking buffer (5% nonfat
dry milk, 2.7 mM KCl, 137 mM NaCl, 8 mM NaHPO4,
1.4 mM KPO4 and 0.1% Tween 20) for 2 h at room temper-
ature. Then incubation with the monoclonal antibody anti-β
actin (1:1,000 diluted in blocking buffer, Zhongshan Golden
Bridge Biotechnology, China), anti-Grp78 (1:500) anti-
Casepase12 (1:1,000) was performed overnight at 4°C, then
incubation with secondary antibody (anti-rabbit, anti-rat and
anti-goat IgG conjugated to HRP, in blocking buffer 1:1,000,
Zhongshan Golden Bridge Biotechnology, China) lasted 1 h,
also at room temperature. The reaction was visualized by
chemiluminescence (Enhanced Chemiluminescent Kit,
ECL, Amersham). The film was scanned with an imaging
densitometer (fluorchem HD IS-9900, Alpha, CA) and the
optical density was quantified using Multi-Analyst software.
Statistics
All the results are expressed as mean ± SD. The individual
groups were tested for differences by using one-way ANOVA
repeated measurements followed by independent samples




The body weight and blood glucose levels are shown in
Fig. 1A and B. Left ventricular systolic function parameters,
fractional shortening (%) and ejection fraction of the diabetic
animals were significantly reduced compared to their 1st
week levels and normal animals at 16 weeks (Table 2). Left
ventricular diastolic function variables expressed by the E-
wave (early diastolic filling, early peak velocity) and A-wave
(late atrial filling, atrial peak velocity) differed significantly in
diabetic animals compared to their 1st week levels and normal
animals at 16 weeks. A significant decrease was found in the E-
wave velocity, increase in the A-wave velocity and significant
decrease in the E/A ratio after 16 weeks in the diabetic groups,
with a significant decrease in the fractional shortening and
ejection fraction. The altered cardiac diastolic performance
is thought to result from a reduced cardiac compliance.
Haematoxylin-eosin, TUNEL and histological studies
With hematoxylin-eosin and TUNEL staining, the charac-
teristics of diabetic cardiomyopathy and more apoptotic
cardiocytes and endothelial cells were found in diabetic
Fig. 1.  A: Body weight in the diabetic rats was significantly decreased at 16 weeks compared to their 1 week levels and normal rats
(p<0.05). The body weight of normal rats increased at 16weeks compared to their 1week levels (p<0.05). B: Blood glucose
levels in the diabetic animals have shown a significant raise at 1week after diabetes induction compared to the normal rats
(p<0.05). A significant increase in the blood glucose was observed in diabetic rats at 16 weeks.Z. Li et al.
J. Clin. Biochem. Nutr.
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Fig. 2.  A, B: The normal (A) and diabetic (B) myocardium were stained with haematoxylin-eosin, diabetic cardiac muscle fibers were
disorder and many of them were collapsed, diabetic myocardium showed fibrosis and extensive focal coalescent areas of
ischemic myocyte degeneration in the subendocardial, subepicardial region and papillary muscles of the myocardium. 
Fig. 2.  C, D, E: Diabetic heart (E) showed more TUNEL-positive cardiocytes and endothelial cells than normal (D) heart (p<0.05). C
was negative control. ER Stress in Diabetic Myocardial Apoptosis
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Fig. 2.  F, G, H, I, J, K, L, M, N: Immunoreactive Grp78 and Caspase12 of sections from diabetic heart (H: Grp78; K: Caspase12) and
normal heart (G: Grp78; J: Caspase12) were shown. The diabetic heart showed strong immunoreactivity for Grp78 (p<0.05) and
Caspase12 (p<0.05). F (Grp78) and I (Caspase12) were negative control. Bar=50 µm.Z. Li et al.
J. Clin. Biochem. Nutr.
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group. Correspondingly, the two ERS hallmarks, Grp78
and Caspase12, in the diabetic heart showed strong
immunoreactivity than normal group. (Fig. 2 A–N)
mRNA expression
PCR analysis performed on total RNA showed that Grp78
and Caspase12 mRNA in both diabetic and normal hearts
were easily detectable. However, the Grp78 (or Caspase12)/
GAPDH densitometric ratio in the diabetic group was higher
than normal group. (Fig. 3 A–B)
Western blot
Representative results of Western blot analysis are shown
in Fig. 4. With an antibody against Caspase12, samples of
normal rat myocardium showed a band with a molecular
weight of 50 kDa, and a weak band with a molecular of
30 kDa were also found. This means that there was a slight
Caspase12 activation even in the normal state. Two bands at
30 kDa in the diabetic rats could be found as the result of
more pro-Caspase12 was activated. (Fig. 4 A–C)
Discussion
Diabetic cardiomyopathy is characterized by both systolic
and diastolic dysfunction [22]. In the current study, we
established type 1 diabetic rat model and used echocardio-
graphy to identify the existence of diabetic cardiomyopathy
in them. The result of TUNEL stain suggested that more
cardiocytes and endothelial cells were apoptosis in the
diabetic hearts. We demonstrated that Grp78 has enhanced
expression in the diabetic heart, which suggested that ERS
was induced in our experimental paradigm. Caspase12, an
ER-associated caspase, had strong immunogenicity and
more cleaved fragment in the diabetic heart, which indicated
that ERS-associated apoptosis pathway was activated. This
is the first study that implicates ER-stress plays a role in the
pathophysiology of diabetic cardiomyopathy.
Cell death, as a comprehensive consequence of abnormal
cellular metabolism and gene expression in response to
hyperglycemia, has been considered to be the important
cause of diabetic cardiomyopathy. Because myocytes rarely
proliferate in adult cardiac muscles, the loss of cardiocytes
would eventually lead to compromised cardiac function. Loss
of endothelial cells will lead vascular to dysfunction and
aggravate the ischemia of the heart. Apoptosis of cardiocytes
and endothelial cells has been observed in the heart of
patient with diabetes and in STZ-induced diabetic rat [10,
11]. Exposing to high glucose also induced the two types of
cells to death in vitro [23, 24]. Recent study showed high
glucose could increase apoptosis of cultured lens epithelial
cells through ERS pathway [25], and in current study, the
cleaved Caspase12 enhanced expression also indicated ERS-
associated apoptosis was activated in diabetic myocardium.
Indeed, besides hyperglycemia, diabetic heart experiences
many other conditions that can invoke ERS, such as increased
oxidative stress, hypoxia, homocysteine, lipid deposition
[26], and increased synthesis of secretory proteins [27–29].
Recent study showed in hypertrophic and failing heart after
aortic constriction, ERS was induced by angiotensin II,
which was also increased in diabetic heart [1,  2,  18].
Fig. 3.  A, B: The expression of both Grp78 and Caspase12 mRNA in the diabetic heart increased significantly compared to the normal
heart tissue. Furthermore, the two targets were regulated in the same manner at mRNA level, which are statistically significant
difference (p<0.05).ER Stress in Diabetic Myocardial Apoptosis
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Previous studies have shown the ER was swelling in diabetic
myocardium, which gave ultrastructural evidence for the
ERS in diabetic heart [19, 20].
As one of intrinsic pathways of apoptosis, ERS implicates
several proteins including the transcription factor
GADD153/CHOP (growth arrest and DNA damage, also
called CHOP) [30], the JNK-pathway [31], and the ER-
resident cysteine protease, Caspase12. Nakagawa et al. [15]
demonstrated that Caspase12 mediated apoptosis was a
specific apoptosis pathway of ER, and apoptosis that
occurred as a result of membrane- or mitochondrial-targeted
signals did not activate Caspase12. Grp78, an ER chaperone
protein, is a well-established hallmark of ERS. Increased
Grp78 was reported in ERS-associated apoptosis of
pancreatic β cells [15], renal proximal tubular cells [32],
cardiocytes in heart failure [19], and endothelial cells [33].
In current study, enhanced expression of Grp78 was also
found in apoptosis of diabetic myocardium.
In summary, this study provided the first evidence that
Grp78 increased and Caspase12 is activated in the diabetic
heart. This meant ERS was involved in the pathology of
diabetic cardiomyopathy, and ERS-associated apoptosis
acted roles in diabetic heart failure. It will be a potential
therapeutic target for diabetic cardiomyopathy.
Fig. 4.  A, B, C: With antibody against Grp78, a weak band was detectable in samples of normal rats myocardium, but those of diabetic
rats showed a single strong band with a molecular weight of 78 kDa (p<0.05). With an antibody against Caspase12, samples of
normal rat myocardium showed a band with a molecular weight of 50 kDa, and a weak band with a molecular of 30 kDa was
also found. While in diabetic rats’ myocardium, the pro- and cleaved-Caspase12 with a molecular weight between 50–30 kDa
was obviously found. With quantitative analysis, we found that more Caspase12 were activated in diabetic heart (p<0.05).Z. Li et al.
J. Clin. Biochem. Nutr.
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